James Cho, MD
Psychiatry · Saint Louis, MONPI 1376706754
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $89,525 of the $118,242 with a category attached, or 75.7%. 34 manufacturers reported payments, led by AbbVie at 54.1% of the total. Among psychiatry clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,059 payments — averaging $111.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$64K
- Supernus Pharmaceuticals, Inc.$37K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Corium, LLC$2K
- Teva Pharmaceuticals USA, Inc.$2K
- Otsuka America Pharmaceutical, Inc.$2K
- plus $9K from 28 others
What the payments were for
- Speaking & faculty fees$89,52576%
- Travel & lodging$6,7436%
- Food & beverage$21,72718%
- Education$2470%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$118,242 in reported general payments places this provider in the 95th percentile of 680 psychiatry providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 11 | $153,104 |
| AuvelityDextromethorphan Hbr/Bupropion | 59 | $95,679 |
| RexultiBrexpiprazole | 38 | $75,273 |
| VraylarCariprazine Hcl | 37 | $70,420 |
| FanaptIloperidone | 11 | $31,779 |
| TrintellixVortioxetine Hydrobromide | 32 | $31,727 |
| BelsomraSuvorexant | 35 | $17,712 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 41 | $6,279 |
| Lurasidone Hcl | 16 | $5,146 |
| Ramelteon | 29 | $4,806 |
| Bupropion XlBupropion Hcl | 139 | $4,715 |
| Buspirone Hcl | 151 | $4,347 |
| Aripiprazole | 24 | $3,672 |
| Vilazodone Hcl | 27 | $3,475 |
| Gabapentin | 74 | $2,211 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $1,767 | $153,10411 claims |
| Axsome Therapeutics, Inc.Auvelity | $1,399 | $95,67959 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $1,568 | $75,27338 claims |
| AbbVieVraylar | $63,919 | $70,42037 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $494 | $31,77911 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $712 | $31,72732 claims |
| MerckBelsomra | $211 | $17,71235 claims |
| Almatica Pharma LLCSertraline Hcl | $66 | $23428 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 680 psychiatry providers in Missouri.
Other psychiatry in Saint Louis
- Vadim BaramSaint Louis$1.9M
- Adam SkySaint Louis$1.1M
- Mohd MalikSaint Louis$956K
- George GrossbergSaint Louis$501K
- Christopher LoyndSaint Louis$265K
- Devnandini RastogiSaint Louis$261K
- Michael StotlerSaint Louis$250K
- Steven HarveySaint Louis$90K
- Kevin BlackSaint Louis$77K
- Eric LenzeSaint Louis$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.